Literature DB >> 33539224

Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism.

Nada A Abumrad1, Ainara G Cabodevilla2, Dmitri Samovski1, Terri Pietka1, Debapriya Basu2, Ira J Goldberg2.   

Abstract

Lipid uptake and metabolism are central to the function of organs such as heart, skeletal muscle, and adipose tissue. Although most heart energy derives from fatty acids (FAs), excess lipid accumulation can cause cardiomyopathy. Similarly, high delivery of cholesterol can initiate coronary artery atherosclerosis. Hearts and arteries-unlike liver and adrenals-have nonfenestrated capillaries and lipid accumulation in both health and disease requires lipid movement from the circulation across the endothelial barrier. This review summarizes recent in vitro and in vivo findings on the importance of endothelial cell receptors and uptake pathways in regulating FAs and cholesterol uptake in normal physiology and cardiovascular disease. We highlight clinical and experimental data on the roles of ECs in lipid supply to tissues, heart, and arterial wall in particular, and how this affects organ metabolism and function. Models of FA uptake into ECs suggest that receptor-mediated uptake predominates at low FA concentrations, such as during fasting, whereas FA uptake during lipolysis of chylomicrons may involve paracellular movement. Similarly, in the setting of an intact arterial endothelial layer, recent and historic data support a role for receptor-mediated processes in the movement of lipoproteins into the subarterial space. We conclude with thoughts on the need to better understand endothelial lipid transfer for fuller comprehension of the pathophysiology of hyperlipidemia, and lipotoxic diseases such as some forms of cardiomyopathy and atherosclerosis.

Entities:  

Keywords:  cardiomyopathy; chylomicrons; fatty acids; lipoprotein; triglyceride

Mesh:

Substances:

Year:  2021        PMID: 33539224      PMCID: PMC7959116          DOI: 10.1161/CIRCRESAHA.120.318003

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  206 in total

1.  Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake.

Authors:  Giulia Coppiello; Maria Collantes; María Salomé Sirerol-Piquer; Sara Vandenwijngaert; Sandra Schoors; Melissa Swinnen; Ine Vandersmissen; Paul Herijgers; Baki Topal; Johannes van Loon; Jan Goffin; Felipe Prósper; Peter Carmeliet; Jose Manuel García-Verdugo; Stefan Janssens; Iván Peñuelas; Xabier L Aranguren; Aernout Luttun
Journal:  Circulation       Date:  2015-01-05       Impact factor: 29.690

2.  Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.

Authors:  Carolina E Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Barbara C Fam; Henrik Ortsäter; Pierre Scotney; Daniel Nyqvist; Erik Samén; Li Lu; Sharon Stone-Elander; Joseph Proietto; Sofianos Andrikopoulos; Ake Sjöholm; Andrew Nash; Ulf Eriksson
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

3.  VIP21/caveolin is a cholesterol-binding protein.

Authors:  M Murata; J Peränen; R Schreiner; F Wieland; T V Kurzchalia; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

5.  Identification of caveolin-1 as a fatty acid binding protein.

Authors:  B L Trigatti; R G Anderson; G E Gerber
Journal:  Biochem Biophys Res Commun       Date:  1999-02-05       Impact factor: 3.575

6.  Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

Authors:  Kalyani G Bharadwaj; Yaeko Hiyama; Yunying Hu; Lesley Ann Huggins; Rajasekhar Ramakrishnan; Nada A Abumrad; Gerald I Shulman; William S Blaner; Ira J Goldberg
Journal:  J Biol Chem       Date:  2010-09-18       Impact factor: 5.157

7.  Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes.

Authors:  Dawn L Brasaemle; Georgia Dolios; Lawrence Shapiro; Rong Wang
Journal:  J Biol Chem       Date:  2004-08-27       Impact factor: 5.157

8.  Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart.

Authors:  C J Fielding
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study.

Authors:  F Parker; J D Bagdade; G F Odland; E L Bierman
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.

Authors:  Y Ren; R L Silverstein; J Allen; J Savill
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Regulation of intestinal immunity by dietary fatty acids.

Authors:  Jinxin Qiu; Yanhui Ma; Ju Qiu
Journal:  Mucosal Immunol       Date:  2022-07-12       Impact factor: 8.701

2.  Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis.

Authors:  Mengyue You; Fan Wu; Meilin Gao; Mengyue Chen; Shu Zeng; Yang Zhang; Wei Zhao; Danyang Li; Li Wei; Xiong Z Ruan; Yaxi Chen
Journal:  Redox Biol       Date:  2022-10-07       Impact factor: 10.787

Review 3.  Addressing dyslipidemic risk beyond LDL-cholesterol.

Authors:  Alan R Tall; David G Thomas; Ainara G Gonzalez-Cabodevilla; Ira J Goldberg
Journal:  J Clin Invest       Date:  2022-01-04       Impact factor: 14.808

Review 4.  CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis.

Authors:  Jan F C Glatz; Miranda Nabben; Joost J F P Luiken
Journal:  Curr Opin Lipidol       Date:  2022-04-01       Impact factor: 4.776

Review 5.  Targeting the vasculature in cardiometabolic disease.

Authors:  Nabil E Boutagy; Abhishek K Singh; William C Sessa
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

6.  EVOO Promotes a Less Atherogenic Profile Than Sunflower Oil in Smooth Muscle Cells Through the Extracellular Vesicles Secreted by Endothelial Cells.

Authors:  Concepción Santiago-Fernandez; Cristina Rodríguez-Díaz; Ailec Ho-Plagaro; Carolina Gutierrez-Repiso; Wilfredo Oliva-Olivera; Flores Martin-Reyes; Virginia Mela; Rocío Bautista; Mónicas Tome; Josefa Gómez-Maldonado; Francisco J Tinahones; Eduardo Garcia-Fuentes; Lourdes Garrido-Sánchez
Journal:  Front Nutr       Date:  2022-04-12

Review 7.  A Potential Interplay between HDLs and Adiponectin in Promoting Endothelial Dysfunction in Obesity.

Authors:  Monica Zocchi; Matteo Della Porta; Federico Lombardoni; Roberta Scrimieri; Gian Vincenzo Zuccotti; Jeanette A Maier; Roberta Cazzola
Journal:  Biomedicines       Date:  2022-06-07

Review 8.  Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.

Authors:  Shilu Luo; Ming Yang; Hao Zhao; Yachun Han; Na Jiang; Jinfei Yang; Wei Chen; Chenrui Li; Yan Liu; Chanyue Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

Review 9.  Cardiac Metabolism and Contractile Function in Mice with Reduced Trans-Endothelial Fatty Acid Transport.

Authors:  Tatsuya Iso; Masahiko Kurabayashi
Journal:  Metabolites       Date:  2021-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.